|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/22/21 Sigma Labs, Inc. 10-Q 3/31/21 44:2.7M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 199K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 18K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 18K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K
11: R1 Document and Entity Information HTML 43K
12: R2 Condensed Balance Sheets (Unaudited) HTML 124K
13: R3 Condensed Balance Sheets (Unaudited) HTML 32K
(Parenthetical)
14: R4 Condensed Statements of Operations (Unaudited) HTML 105K
15: R5 Statement of Stockholders' Equity (Unaudited) HTML 90K
16: R6 Condensed Statements of Cash Flows (Unaudited) HTML 100K
17: R7 Summary of Significant Accounting Policies HTML 38K
18: R8 Inventory HTML 20K
19: R9 Deferral of Social Security Tax Payments HTML 17K
20: R10 Derivative Liability HTML 27K
21: R11 Stockholders' Equity HTML 76K
22: R12 Subsequent Events HTML 17K
23: R13 Summary of Significant Accounting Policies HTML 49K
(Policies)
24: R14 Summary of Significant Accounting Policies HTML 38K
(Tables)
25: R15 Inventory (Tables) HTML 20K
26: R16 Derivative Liability (Tables) HTML 25K
27: R17 Stockholders' Equity (Tables) HTML 59K
28: R18 Summary of Significant Accounting Policies HTML 21K
(Details Narrative)
29: R19 Summary of Significant Accounting Policies - HTML 17K
Schedule of Warrant Liability Measured on
Recurring Basis (Details)
30: R20 Summary of Significant Accounting Policies - HTML 20K
Schedule of Derivative Liability Measured on a
Recurring Basis Using Significant Unobservable
Input (Level 3) (Details)
31: R21 Summary of Significant Accounting Policies - HTML 24K
Schedule of Antidilutive Securities Excluded from
Computation of Earnings Per Share (Details)
32: R22 Summary of Significant Accounting Policies - HTML 22K
Schedule of Earnings Per Share, Basic and Diluted
(Details)
33: R23 Inventory - Schedule of Inventory (Details) HTML 23K
34: R24 Deferral of Social Security Tax Payments (Details HTML 21K
Narrative)
35: R25 Derivative Liability (Details Narrative) HTML 27K
36: R26 Derivative Liability - Schedule of Fair Value of HTML 26K
Derivative Liability Using Black Scholes Valuation
Model (Details)
37: R27 Derivative Liability - Schedule of Fair Value of HTML 23K
Warrant Liability (Details)
38: R28 Stockholders' Equity (Details Narrative) HTML 167K
39: R29 Stockholders' Equity - Schedule of Share-based HTML 31K
Payment Award, Stock Options, Valuation
Assumptions (Details)
40: R30 Stockholders' Equity - Schedule of Stock Option HTML 101K
Activity (Details)
41: R31 Stockholders' Equity - Summary of Warrant Activity HTML 40K
(Details)
43: XML IDEA XML File -- Filing Summary XML 74K
42: EXCEL IDEA Workbook of Financial Reports XLSX 50K
5: EX-101.INS XBRL Instance -- sglb-20210331 XML 722K
7: EX-101.CAL XBRL Calculations -- sglb-20210331_cal XML 122K
8: EX-101.DEF XBRL Definitions -- sglb-20210331_def XML 314K
9: EX-101.LAB XBRL Labels -- sglb-20210331_lab XML 741K
10: EX-101.PRE XBRL Presentations -- sglb-20210331_pre XML 495K
6: EX-101.SCH XBRL Schema -- sglb-20210331 XSD 116K
44: ZIP XBRL Zipped Folder -- 0001493152-21-009466-xbrl Zip 80K
Exhibit 32.1
Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Mark K. Ruport, the Chief Executive Officer, and Frank Orzechowski, the Chief Financial Officer, of Sigma Labs, Inc. (the “Company”), hereby certify, that, to their knowledge:
1. The Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| /s/ Mark K. Ruport | /s/ Frank Orzechowski | |
| Mark K. Ruport | Frank Orzechowski | |
|
President and Chief Executive Officer (Principal Executive Officer) |
Chief Financial Officer, Treasurer (Principal Financial and Accounting Officer) | |
| April 22, 2021 | April 22, 2021 |
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/22/21 | 8-K | ||
| For Period end: | 3/31/21 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/14/23 Sigma Additive Solutions, Inc. 424B5 1:457K M2 Compliance LLC/FA 9/14/21 Sigma Additive Solutions, Inc. S-8 9/14/21 3:198K M2 Compliance LLC/FA 8/10/21 Sigma Additive Solutions, Inc. S-8 8/10/21 3:127K M2 Compliance LLC/FA 7/02/21 Sigma Additive Solutions, Inc. 424B5 1:524K M2 Compliance LLC/FA 6/21/21 Sigma Additive Solutions, Inc. 424B3 1:227K M2 Compliance LLC/FA 6/11/21 Sigma Additive Solutions, Inc. S-3 4:1.1M M2 Compliance LLC/FA 6/09/21 Sigma Additive Solutions, Inc. S-3 3:337K M2 Compliance LLC/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/21 Sigma Additive Solutions, Inc. 8-K:1,3,8,9 3/25/21 7:589K M2 Compliance LLC/FA 1/12/21 Sigma Additive Solutions, Inc. 8-K:1,3,8,9 1/08/21 9:676K M2 Compliance LLC/FA |